“Controversies in Cardiovascular Medicine”
DATES: Thursday 26 – Friday 27 September 2019
LOCATION: Keble College, Oxford
Registration deadline extension: Monday 9 September
Programme & Flier Downloads:
Download our 2019 programme here.
Download our 2019 flier here.
Abstract submission – CLOSED
HUGH SINCLAIR LECTURE: |
|
Professor Ira TABAS (Columbia University, USA) “Efferocytosis and Resolution of Inflammation in Atherosclerosis” |
|
Sessions and speakers |
|
NOVEL INSIGHTS FROM LARGE BIOBANKS | |
UK Biobank: creative problems – Rory COLLINS (Oxford, UK). | |
Supporting cardiovascular drug development through human genomics – Aroon HINGORANI (London, UK) | |
CULPRIT CELLS IN ATHEROSCLEROTIC PLAQUES | |
Vascular smooth muscle cell plasticity in atherosclerosis – Martin BENNETT (Cambridge, UK) | |
Extravasation of immune cells: Role of neutrophils in atherosclerosis – Oliver SOEHNLEIN (Munich, GERMANY) | |
INFLAMMATION versus LIPIDS: RESIDUAL INFLAMMATORY RISK | |
IL-1: a success story of an anti-inflammatory target in CVD – Sheila FRANCIS (Sheffield, UK) | |
Targeting oxidized lipids and oxidation-specific epitopes in atherosclerosis – Christoph BINDER (Vienna, AUSTRIA) | |
Challenges in translating cardiovascular strategies using advanced therapy medicinal products – Andrew BAKER (Edinburgh, UK) | |
LIPIDS versus INFLAMMATION: RESIDUAL LIPID RISK BEYOND LDL-C | |
The biology of PCSK9: beyond LDLC lowering – Alberico CATAPANO (Milan, ITALY) | |
Novel lipid targets for CVD – Anne TYBJAERG-HANSEN (Copenhagen, DENMARK) | |
Lipoprotein (a) and antisense therapy – Sam TSIMIKAS (San Diego, USA) |
This meeting is endorsed by the European Atherosclerosis Society
Sponsors
The BAS gratefully acknowledges the support of our sponsors. Please click on the logos to visit their websites.
Meeting Sponsor
Gold Sponsor
Silver Sponsors
Bronze Sponsors
Getting to Keble College + Oxford:
Keble College, Parks Road, Oxford, OX1 3PG
IMPORTANT – Car parking – please note that there is NO car parking available at Keble.